Great Lakes Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Great Lakes Advisors, LLC

$10.6 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$87.74 - $117.27 $2,632 - $3,518	-30 Reduced 1.25%	2,376 $231,000
Q4 2022 Feb 09, 2023	BUY	$80.93 - $108.63 $194,717 - $261,363	2,406 New	2,406 $248,000
Q2 2022 Aug 09, 2022	SELL	$71.48 - $86.85 $186,062 - $226,070	-2,603 Reduced 44.89%	3,195 $265,000
Q1 2022 May 06, 2022	SELL	$74.28 - $92.69 $264,733 - $330,347	-3,564 Reduced 38.07%	5,798 $447,000
Q4 2021 Feb 09, 2022	SELL	$71.72 - $91.47 $4.18 Million - $5.33 Million	-58,282 Reduced 86.16%	9,362 $827,000
Q3 2021 Nov 09, 2021	SELL	$74.77 - $85.47 $2.35 Million - $2.69 Million	-31,483 Reduced 31.76%	67,644 $5.23 Million
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $1.01 Million - $1.14 Million	13,435 Added 15.68%	99,127 $8.27 Million
Q1 2021 May 03, 2021	BUY	$74.73 - $90.69 $1.45 Million - $1.75 Million	19,347 Added 29.16%	85,692 $6.47 Million
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $92,069 - $114,373	-1,268 Reduced 1.88%	66,345 $5.82 Million
Q3 2020 Nov 04, 2020	BUY	$71.87 - $131.03 $1.04 Million - $1.9 Million	14,519 Added 27.35%	67,613 $5.14 Million
Q2 2020 Aug 07, 2020	SELL	$79.55 - $124.22 $2.89 Million - $4.52 Million	-36,392 Reduced 40.67%	53,094 $6.55 Million
Q1 2020 May 08, 2020	BUY	$71.37 - $96.85 $6.39 Million - $8.67 Million	89,486 New	89,486 $7.56 Million
Q2 2019 Aug 05, 2019	SELL	$80.35 - $93.9 $201,196 - $235,125	-2,504 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$84.2 - $98.62 $210,836 - $246,944	2,504 New	2,504 $222,000
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $199,468 - $264,008	-2,489 Closed	0 $0
Q3 2018 Nov 30, 2018	BUY	$93.92 - $105.72 $233,766 - $263,137	2,489 New	2,489 $241,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Account